PGR and invasive breast carcinoma: Among these types, TNBC characterized by the absence of estrogen receptor (ER) and progesterone receptor (PR) and no HER2 overexpression accounts for 10–20% of invasive breast cancers and shares a considerable overlap with BRCA1-mutated tumors [3, 4].